ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Urogen Pharma Ltd

Urogen Pharma Ltd (0XOD)

0.00
0.00
( 0.00% )

Income Statement

Balance Sheet

Cash Flow

Year End 31 December 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 17.53M8.16M1.13M18k11.8M48.04M64.36M82.71M
Operating Income 798k-19.95M-77.18M-109.48M-126.74M-92.29M-79.04M-65.54M
Pre Tax Income -1.94M-19.98M-75.53M-105.15M-125.11M-109.37M-108.03M-98.32M
Net Income -1.94M-20M-75.66M-105.15M-128.48M-110.82M-109.78M-102.24M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -0.259-1.056-3.534-4.01-4.696-4.007-3.876-2.835
EBIT 798k-19.95M-77.3M-109.76M-126.74M-92.29M-78.97M-64.7M
EBITDA 1.01M-19.74M-76.76M-109.18M-126.32M-91.46M-78.12M-64.73M